Everyday Health Sulfonylurea stimulates the release of insulin from the pancreas. While the medication does work quickly, it may cause severe low blood sugar, weight gain, nausea, and skin rashes. TZD, or Thiazolidinedione , helps improve the body's sensitivity to ... and more »
Medscape In addition to the major risk factors for osteoporotic fracture, low bone mineral density (BMD), age, low body weight and history of fracture or falls, some drugs are now considered to be important secondary risk factor for bone loss and fracture ... and more »
HealthDay The researchers found that around 40 percent of people taking a sulfonylurea, a thiazolidinedione , or a dipeptidyl peptidase 4 inhibitor (DPP-4 inhibitor) ad...
NICE It is an oral, once-daily medication belonging to a class of drugs called sodium glucose co-transporter (SGLT-2) inhibitors. The draft guidance is now with cons...
Diabetes News Journal In this study, the authors performed a retrospective analysis and determined how the use of thiazolidinediones (TZDs, a class of drugs used in the treatment of diabetes mellitus type 2) impacts the necessity for re-intervention in diabetic patients ...
Clinical Advisor Clinical trials: Tanzeum was studied as monotherapy and in combination with metformin, metformin + sulfonylurea, thiazolidinedione ± metformin, and insulin glargine ± oral antidiabetics. The efficacy of Tanzeum was compared with placebo, glimepiride, ...
MarketWatch Higher frequency of weight gain and edema was observed in patients taking both LYRICA and thiazolidinedione antidiabetic drugs . Exercise caution when coadministering these drugs . Patients who are taking other drugs associated with angioedema such as ... and more »
AJMC.com Managed Markets Network A meta-analysis on the thiazolidinedione drug , rosiglitazone, raised concerns over increased risk of death from CV causes, 10 and a nationwide observational cohort study suggested increased CV risk with sulfonylureas compared with metformin. 10,11 Such ...
